Secondaries archive
Every Secondaries story, newest first. 113 stories
4 stories
- GP-led deals
Sun Capital closes Anderson Global continuation vehicle with no disclosed price
The vehicle gives Fund VIII LPs a liquidity option or a roll, and neither its size nor any lead buyer was disclosed.
- GP-led deals
Reach Capital's William Barrett floats €1bn-a-year GP-led budgets for CDPQ and Allianz
A standing €1bn-a-year commitment from each would add €2bn of annual GP-led demand, though the published extract reports a hypothetical and not an announced budget.
- The Wrap
Sun Capital closes second continuation vehicle; Ibex closes $87 million secondaries fund
The Anderson Global vehicle gives Fund VIII LPs a liquidity option or a roll, but no price, size, or lead buyer was disclosed.
- GP-led deals
Sun Capital closes second continuation vehicle of 2026 for Anderson Global
The vehicle gives Fund VIII LPs a liquidity option or the chance to roll; the report carries no price, size or lead buyer.
3 stories
- The Wrap
Ibex closes second Israel-focused secondaries fund at $87 million
AltAssets reported the close on 28 September, the week's only clean fundraising figure as larger secondaries deals printed without asset marks.
- The Wrap
Anchorage Capital GP stake prints at $4.7 billion with no asset mark
A $101 million bank sale and three GP-led continuation vehicles closed without asset-level prices, leaving the week's secondaries tape anchored to a management company's fee stream.
- Fundraising
Ibex closes second Israel secondaries fund at $87m, more than doubling its predecessor
AltAssets reported the close on 28 September; the accessible page carries no LP base, target or strategy detail.
2 stories
- The Wrap
A bank set the only price secondaries printed this week
Three GP-led continuation vehicles closed without a mark, and the absence is the mechanism: buyers are underwriting the sponsor's valuation rather than the company underneath.
- The Wrap
Secondaries cleared everything this week except the assets
A $101 million bank balance-sheet sale and a $4.7 billion Orix–Anchorage GP stake printed; three continuation vehicles closed without an asset-level mark.
2 stories
- The Wrap
The $101 million print cannot mark an unpriced continuation vehicle
A bank's balance-sheet sale is not an asset mark, and the week's three unpriced continuation vehicles show the GP-led market still has no external anchor.
- The Wrap
GP stakes clear the secondaries backlog
A $4.7 billion Orix–Anchorage Capital closing shows capital moving through manager economics while LP-led trades stay stalled.
2 stories
- The Wrap
Aging funds and sponsor price optimism stall the LP-led market
BDO's research pairs a longer tail of funds past five years with sponsor expectations of higher prices, leaving voluntary LP sellers unwilling to trade below marks.
- LP portfolio sales
Aging PE holds swell LP supply; GP price optimism stalls it
BDO's research points to a longer tail of funds running past five years just as sponsors tell surveyors they expect to buy at higher prices, a pairing that suggests LP-led books will price slowly rather than cheaply.
2 stories
- Fundraising
Guardian Alarm shows benchmark-free CV pricing is now the default
Three GP-led continuation vehicles closed without a published mark, including Guardian Alarm's security-services deal; the LP-led side printed one number. Sponsor valuations now set the price from fertility to security services.
- GP-led deals
Certares and New 2ND Capital close an unpriced Guardian Alarm continuation vehicle
Four days after Amulet's unpriced fertility CV, the GP-led market has another closed deal whose mark nobody outside the room can see.
2 stories
- The Wrap
A $101 million print forces the CV debate
Priced LP-led trades give buyers a benchmark to use against Amulet's unpriced US Fertility continuation vehicle.
- The Wrap
Two secondary pricing regimes, and only one has an anchor
A $101 million bank position and a Dutch pension fund set one reference for the week's LP-led supply; Amulet's US Fertility continuation vehicle closes with no published price, leaving buyers to run two underwriting models.
3 stories
- The Wrap
Banks and pensions are restocking the LP-led secondaries market
A $101 million bank position and a BlackRock agreement with a Dutch pension fund are the week's real supply story, and sellers like these price off the balance sheet rather than the asset.
- GP-led deals
Amulet closes a US Fertility continuation vehicle with no reported price
The fertility comp is a number the sponsor and lead buyer keep to themselves.
- The Wrap
The continuation vehicle's second life
Built to hand LPs an exit, the continuation vehicle has become a front door for small LPs — and their OCIO may be standing in it first.
3 stories
- GP-led deals
Small LPs turn GP-led deals into an on-ramp
A structure built to hand LPs an exit is being bought by LPs who want an entrance—and the OCIO's seat sits ahead of its clients' capital.
- The Wrap
StepStone's fertility CV prices equity like credit
A benchmark-free fertility continuation vehicle shows the GP-led market now prices services assets off the sponsor's mark rather than the tape.
- The Wrap
Secondaries dry powder finds its home in unglamorous CVs
Single-asset continuation vehicles for a fitness-equipment maker and a shipping franchise are clearing while the mega LP portfolios wait.
2 stories
- The Wrap
Secondaries' barrier is talent, not money
A $1 billion pre-hire commitment and an allocator's launch show capital now follows people.
- GP-led deals
Golub buys secondaries sourcing, not a strategy
The $1bn was committed before the hire, and a market with too much capital and too few invitations now pays for relationships rather than vehicles.
1 story
- Fundraising
A Children's Health allocator leaves to build a secondaries firm
Gordian Investment Group's premise that execution rather than capital is the secondaries bottleneck will be tested on precisely the deals other buyers walk away from.
4 stories
- GP-led deals
StepStone leads a US Fertility continuation vehicle, and the price stays private
A single-asset fertility deal arrives with a family count in the headline and no valuation anywhere in it.
- The Wrap
Watch the discount on India's CV pipeline
Hong Kong panelists expect Indian secondaries exits to precede fundraises, and a negative buyout benchmark gives buyers the cover to price continuation vehicles below sponsor marks.
- The Wrap
India will sell continuation vehicles before it raises. Watch the discount
Indian sponsors are expected to run secondaries exits ahead of fundraises, putting the GP-led desk in the position of underwriting sponsor marks against a buyout benchmark that has just turned negative.
- GP-led deals
India's DPI pressure is the GP-led desk's next pipeline
Panelists at a Hong Kong private equity forum expect secondaries exits to precede Indian fundraises, sending supply to buyers who price off sponsor marks.
3 stories
- The Wrap
TrueBridge's $508 million splits the secondary market in two
Venture buyers get the discount, the GP-led side gets the sponsor's number, and HarbourVest's negative quarter draws the line.
- LP portfolio sales
OCIOs buy GP-led secondaries for deployment speed
Speed-first buyers have already accepted the sponsor's mark.
- The Wrap
Two CVs close. Two pricing regimes. One day.
Pantheon's €1.2bn credit CV has no public benchmark; Kelso's $510m MEP CV is ordinary. Each prices on terms, not marks.
2 stories
- The Wrap
A €1.2bn credit CV has no public benchmark. The terms are the price.
Credit's arrival in the GP-led market moves the pricing question off published comps and onto covenants, rollover terms and one lead buyer's underwriting.
- The Wrap
Kelso's $510 million MEP continuation makes GP-led secondaries ordinary
The sticker price says little; the rollover, fees, and covenants will decide whether this middle-market exit works.
4 stories
- GP-led deals
Peterson's Kelso continuation shows GP-leds going routine
The $510 million fund for a Utah mechanical, electrical and plumbing contractor is the GP-led market's mundane face: the trade's real content sits in the terms, not the headline.
- GP-led deals
Gainline rolls Core Health into StepStone-led continuation
The single-asset vehicle gives existing LPs a liquidity option while adding fresh capital to fund the fitness equipment maker's expansion.
- GP-led deals
Pantheon leads €1.2bn Bridgepoint Credit continuation
The second Bridgepoint-Pantheon GP-led in two days prices an illiquid credit book with no public benchmark.
- Fundraising
TrueBridge’s $508m secondaries fund doubles the strategy
The firm more than doubled its venture secondaries pool; the test is whether it can deploy the money at disciplined discounts.
1 story
- GP-led deals
Hudson Hill closes single-asset CV for InXpress
PE Hub reports the close for the freight and parcel services provider, with no valuation, vehicle size, or investor names disclosed.